IL-HYATT-HOTELS
14.7.2022 14:02:11 CEST | Business Wire | Press release
To share progress made across World of Care, the company’s Environmental, Social and Governance (ESG) platform, Hyatt Hotels Corporation (NYSE: H) today published its 2021 World of Care Highlights and Diversity, Equity and Inclusion (DE&I) Report to demonstrate how Hyatt is advancing care for the planet, people and responsible business.
“Caring for people so they can be their best has been at the core of Hyatt’s story for 65 years. Through World of Care, we embrace our responsibility and opportunity to work together to shape a more sustainable world and future,” said Margaret Egan, executive vice president and general counsel, Hyatt. “By intently focusing on driving progress against key ESG commitments like our environmental framework and Change Starts Here goals, we are holding ourselves accountable for continued action and progress in order to create the needed changes for our industry, society and planet.”
Hyatt Advances Diverse Workforce Representation
Following last year’s inaugural DE&I report, Hyatt’s 2021 workforce diversity data shows increased levels of representation of people of color across its U.S. workforce, as well as growth across nearly all races and ethnicities among colleagues, managers and leaders. Hyatt’s commitment to share progress annually serves as a critical benchmark to measure the strides made toward a more diverse, equitable and inclusive environment for colleagues.
Hyatt continues to work toward its 2025 DE&I goals around who it employs, supports and works with, outlined as part of its Change Starts Here commitments. With a focus on improving diverse vendor representation across its supply chain, Hyatt welcomed 220 new Black suppliers in 2021, with a continued focus on advancing progress looking ahead. For example, Revival Baltimore, which is part of the JdV by Hyatt brand, worked with Black-owned Black Acres Roastery to supply coffee to all hotel guestrooms and the property’s onsite coffee shop, ‘Dashery, and Hyatt Centric The Pike Long Beach recently welcomed Black-owned brewery Crowns & Hops to its Watercraft Lounge.
“At Hyatt, we believe in the power of belonging – of making people feel at home no matter where they are in the world. We constantly strive to reflect the world we care for with teams that achieve and grow together,” said Malaika Myers, chief human resources officer, Hyatt. “To advance our vision of a world of understanding and care, we must continue to prioritize DE&I across every dimension of our business and take action to make meaningful progress against our goals.”
Hyatt Announces Donation to Launch Human Trafficking Survivor Fund
In an effort to expand the hotel industry’s ongoing work to support human trafficking prevention and survivors, the Hyatt Hotels Foundation has announced a $500,000 donation to launch the “No Room for Trafficking Survivors Fund” in collaboration with the American Hotel & Lodging Association (AHLA). With the donation, and further support from the industry, the Survivors Fund will equip community-based organizations with the resources they need to engage and support survivors – from direct financial support of their short-term, baseline needs to career-related support that can empower and equip them on their path forward.
Hyatt Works to Advance Climate Action
Hyatt further accelerates its efforts to engage in more sustainable business practices as part of its environmental framework – focused on areas of climate change and water conservation, waste and circularity, responsible sourcing and thriving destinations.
In 2021, Hyatt received approval from the Science Based Targets initiative (SBTi) on its 2030 science-based target to reduce greenhouse gas emissions. Hyatt’s targets include reducing absolute scope 1 and 2 emissions, engaging key suppliers to set science-based targets by 2025, and decreasing additional scope 3 emissions.
Hyatt remains diligent in promoting initiatives that support progress toward its science-based target, which focus on energy conservation, efficient technology, building automation systems, advancing sustainable design considerations and more. An important ongoing focus will be on increasing the number of hotels that have on-site solar panels or are using one-hundred percent renewable electricity such as Hyatt Regency Amsterdam and Hyatt Regency Phoenix. Ongoing property efforts are also critical in achieving these targets, such as the ones displayed at Alila Villas Uluwatu through its on-site sustainability lab .
To learn more about Hyatt’s ESG efforts and progress, visit Hyatt.com/WorldofCare or browse the 2021 World of Care Highlights , 2021 DE&I Report and 2021 GRI Index .
The term “Hyatt” is used in this release for convenience to refer to Hyatt Hotels Corporation and/or one or more of its affiliates.
About Hyatt Hotels Corporation
Hyatt Hotels Corporation, headquartered in Chicago, is a leading global hospitality company guided by its purpose – to care for people so they can be their best. As of March 31, 2022, the Company’s portfolio included more than 1,150 hotels and all-inclusive properties in 71 countries across six continents. The Company's offering includes the Park Hyatt®, Miraval®, Grand Hyatt®, Alila®, Andaz®, The Unbound Collection by Hyatt®, Destination by Hyatt™, Hyatt Regency®, Hyatt®, Hyatt Ziva™, Hyatt Zilara™, Thompson Hotels®, Hyatt Centric®, Caption by Hyatt, JdV by Hyatt™, Hyatt House®, Hyatt Place®, UrCove, and Hyatt Residence Club® brands, as well as resort and hotel brands under the AMR™ Collection, including Secrets® Resorts & Spas, Dreams® Resorts & Spas, Breathless Resorts & Spas®, Zoëtry® Wellness & Spa Resorts, Vivid Hotels & Resorts®, Alua Hotels & Resorts®, and Sunscape® Resorts & Spas. Subsidiaries of the Company operate the World of Hyatt® loyalty program, ALG Vacations®, Unlimited Vacation Club®, Amstar DMC destination management services, and Trisept Solutions® technology services. For more information, please visit www.hyatt.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220713005967/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
